Foghorn Therapeutics 

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.86-$10.25
Market Cap
$290.8M
Shares Short
918,043

Financials

See more
Revenue (12 Mos)
$25.5M
Revenue Growth (YoY)
-55.3%
Gross Profit (12 Mos)
-$82.2M
Diluted EPS
-$1.85

News

See more

Yahoo Finance • last year

Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update

Yahoo Finance • last year

Foghorn Therapeutics to Present at Upcoming Conferences Including New Preclinical Data from EP300 and CBP Selective Degrader Programs

Yahoo Finance • last year

Foghorn Therapeutics Announces Clinical Data From Phase 1 Study of FHD-286 in Metastatic Uveal Melanoma to Be Presented at ESMO Congress

Yahoo Finance • last year

Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference

About

CEO
Mr. Adrian H. B. Gottschalk
Address
500 Technology Square, Cambridge, MA, United States, 02139
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
116